Search Results

AMG-337 100 mg  | 99.82%

TargetMol

AMG-337 is an effective and highly specific ATP-competitive MET kinase inhibitor. In enzymatic assays, AMG-337(AMG337) inhibits MET kinase activity (IC50: < 5 nM).

More Information Supplier Page

RE-640 5 mg  | 99.91%

TargetMol

NSC5844 (RE640) is a bisquinoline compound with C-C chemokine receptor type 1 (CCR1)-agonistic activities.

More Information Supplier Page

RE-640 10 mg  | 99.91%

TargetMol

NSC5844 (RE640) is a bisquinoline compound with C-C chemokine receptor type 1 (CCR1)-agonistic activities.

More Information Supplier Page

AMG-337 10 mg  | 99.82%

TargetMol

AMG-337 is an effective and highly specific ATP-competitive MET kinase inhibitor. In enzymatic assays, AMG-337(AMG337) inhibits MET kinase activity (IC50: < 5 nM).

More Information Supplier Page

AMG-337 25 mg  | 99.82%

TargetMol

AMG-337 is an effective and highly specific ATP-competitive MET kinase inhibitor. In enzymatic assays, AMG-337(AMG337) inhibits MET kinase activity (IC50: < 5 nM).

More Information Supplier Page